Back to search results

RESET-CKD for Reducing Sedentary Behavior in Adults with Chronic Kidney Disease

This study is testing an intervention called RESET-CKD to help Black adults with chronic kidney disease (CKD) reduce the amount of time they spend sitting. RESET-CKD is a 12-week program that includes health coaching, feedback charts, a workbook, and reminders. Half of the participants will receive RESET-CKD, and the other half will receive education about CKD. Researchers will compare how much sedentary time changes in both groups over 12 weeks. You may be able to join if you are a Black adult aged 35-80 with CKD stages 1-4, sit for 6 or more hours a day, and can speak English and use a phone. The study plans to enroll 40 people, but its current status is unclear.

Study design
This is an interventional study where participants are randomly assigned to either the RESET-CKD intervention or a control group receiving CKD education. It plans to enroll 40 participants.
What's involved
You would participate in a 12-week intervention, which includes health coaching, using feedback charts and a workbook, and receiving reminders. All participants will be followed for 12 weeks.
Compensation
Not stated in the trial record.
Follow-up
All participants will be followed for 12 weeks after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06754280

An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease

Active, Not Recruiting
NAAges 35–80Interventional
University of Illinois at Chicago
~40 participants
Updated 2026-09-02 on ClinicalTrials.gov
What's tested:RESET-CKDAttention Control

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in sedentary time
Measured over Baseline to week 12

Conditions

Chronic Kidney Disease(CKD)

Explore related trials

Chronic Kidney Disease

NCT06754280

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • UI Health/University of Illinois Chicago

    Chicago, Illinoisno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Self-identifies as Black or African American
Age ≥35 to ≤80 years old
CKD Stage 1-4
Self-reported 6 or more hours/day of sedentary time
Ability to speak/read/understand English
Has access to a telephone

Exclusion

Being unable to walk 1 block
Being unable to stand from a seated position without assistance
Using a wheelchair, walker, or cane for all of their ambulation
Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension
Kidney transplant
Any other condition that the investigator considers precludes participation in the trial
Participated in the Patient Advisory Board

What this trial measures

  • Change in sedentary timeBaseline to week 12

    Change in activPAL-measured sedentary time